Industry Valuation and Performance
Has the South Korean Clinical Research and Equipment Industry valuation changed over the past few years?
Date Market Cap Revenue Earnings PE Absolute PE PS Tue, 31 Jan 2023 ₩62.6t ₩3.5t ₩426.6b 20.2x 146.9x 18x Thu, 29 Dec 2022 ₩64.8t ₩3.4t ₩428.7b 20.6x 151.2x 18.9x Sat, 26 Nov 2022 ₩69.8t ₩3.4t ₩445.5b 21.9x 156.6x 20.5x Mon, 24 Oct 2022 ₩65.6t ₩3.0t ₩448.5b 23.1x 146.2x 22x Wed, 21 Sep 2022 ₩62.7t ₩3.0t ₩448.5b 26.4x 139.9x 21x Fri, 19 Aug 2022 ₩69.0t ₩2.7t ₩454.7b 29.5x 151.9x 25.4x Sun, 17 Jul 2022 ₩64.9t ₩2.7t ₩454.7b 28.7x 142.8x 23.9x Tue, 14 Jun 2022 ₩63.6t ₩2.7t ₩454.7b 25.3x 139.8x 23.4x Thu, 12 May 2022 ₩62.9t ₩2.4t ₩379.4b 22.7x 165.7x 25.9x Sat, 09 Apr 2022 ₩60.2t ₩2.4t ₩379.4b 25x 158.8x 24.8x Mon, 07 Mar 2022 ₩57.8t ₩2.4t ₩408.2b 26x 141.7x 24.6x Wed, 02 Feb 2022 ₩55.6t ₩2.3t ₩412.7b 23.7x 134.7x 23.7x Fri, 31 Dec 2021 ₩67.8t ₩2.3t ₩412.7b 28.3x 164.4x 28.9x Sun, 28 Nov 2021 ₩64.9t ₩2.3t ₩390.6b 26.2x 166x 28x Tue, 26 Oct 2021 ₩64.9t ₩2.1t ₩329.9b 27.1x 196.8x 30.2x Thu, 23 Sep 2021 ₩69.7t ₩2.1t ₩329.9b 31.2x 211.2x 32.4x Sat, 21 Aug 2021 ₩73.0t ₩2.2t ₩336.8b 32.9x 216.7x 33x Sat, 05 Jun 2021 ₩64.3t ₩2.1t ₩247.5b 38.6x 259.8x 30.9x Tue, 09 Mar 2021 ₩57.5t ₩2.0t ₩213.0b 64.8x 269.9x 29x Mon, 30 Nov 2020 ₩59.9t ₩1.8t ₩306.1b 59.1x 195.6x 32.4x Thu, 03 Sep 2020 ₩59.4t ₩1.7t ₩273.1b 77.8x 217.6x 36x Sun, 07 Jun 2020 ₩45.7t ₩1.4t ₩209.9b 76.6x 217.7x 32.8x Sat, 29 Feb 2020 ₩34.0t ₩1.2t ₩177.8b 57x 191.1x 28x 1Y 3Y 5Y 10Y Price to Earnings Price to Sales Median Price to Earnings Price to Earnings Ratio
Fri, 07 Feb 2020 Total Market Cap: ₩35.2t Total Earnings: ₩177.8b Total Revenue: ₩1.2t Total Market Cap vs Earnings and Revenue 0% 0% 0% South Korean Clinical Research and Equipment Industry Price to Earnings 3Y Average 189.5x 2021 2022 2023 Current Industry PE Investors are pessimistic on the South Korean Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically. The industry is trading at a PE ratio of 148x which is lower than its 3-year average PE of 189x. The 3-year average PS ratio of 27.8x is higher than the industry's current PS ratio of 18.1x. Past Earnings Growth The earnings for companies in the Life Sciences Tools and Services industry have grown 34% per year over the last three years. Revenues for these companies have grown 42% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too. Industry Comparison
How does South Korean Clinical Research and Equipment compare with similar industries?
7D 1M 3M 1Y 3Y 5Y KR Market 2.46% Healthcare 0.63% Life Sciences 0.46% Clinical Research and Equipment 0.46% Industry PEThere are no additional sub-industries under this industry. Forecasted GrowthThere are no additional sub-industries under this industry. Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
Simply Wall St ™ Simply Wall Street Pty Ltd Level 7, 320 Pitt Street, Sydney
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.